Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AstraZeneca’s R&D Restructuring Follows Hot Spot Trend

This article was originally published in The Pink Sheet Daily

Executive Summary

In its most ambitious overhaul since the reorganization into iMeds in 2010, AstraZeneca’s latest R&D restructuring takes on three basic challenges: accessing innovation, improving internal productivity and reducing complexity and cost. It is the opening salvo in the new CEO’s vision for the troubled pharma.

Advertisement

Related Content

AstraZeneca Says Revamped Pipeline Will Return It To Health, But Pitfalls Remain
Doubling Down On Cardiac Regeneration, AstraZeneca Forms Research Alliance With Shanghai SIBS
AstraZeneca’s Farxiga Label Includes, But Downplays, Bladder Cancer Risk
2013’s Most Notable Stories In “The Pink Sheet” DAILY
AZ Builds Cardiac Regeneration, Diabetes R&D At Swedish Research Hub
European Notebook: Renewed Calls For German Pricing Law Changes, Spain Gauges The Value Of Innovation
Better Late Than Never, J&J’s Innovation Centers Start Opening For Business
AstraZeneca’s Executive Shakeup Includes Global Strategist To Be Named Later
AstraZeneca Rebuilds Its R&D, With Payers In Mind
Pfizer Teams With Eight Boston-Area Research Institutions In $100MM Tie-Up

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS075407

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel